Answers are grounded in this paper and cite their sources.
BACKGROUND: Macrophages in the multiple myeloma (MM) microenvironment adopt diverse functional states that extend beyond the M1/M2 framework. This review examines how spatial niches and metabolic reprogramming shape macrophage function and contribute to therapy resistance. METHODS: We synthesized published mechanistic, single-cell, and spatial profiling studies, focusing on glycolytic, lipid, amino acid, and mitochondrial pathways across hypoxic, vascular, osteolytic, and extramedullary niches. RESULTS: The reviewed evidence suggests that tumor-derived signals, extracellular vesicles, and local metabolic conditions jointly shape macrophage states that can promote immune dysfunction, disease progression, and therapy resistance. Single-cell and spatial profiling studies link macrophage states to cellular neighborhoods, anatomical location, and metabolic context. CONCLUSIONS: Targeting macrophage signaling, metabolism, phagocytic checkpoints, and niche-specific pathways may help overcome therapy resistance in MM. Most supporting evidence comes from preclinical and in vitro studies, and these strategies require clinical validation.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: